Repligen | RGEN - 营业费用

金融业

USD

USD 2.93B

现金及等价物

USD 582.65M

USD 85.97M

USD 1.16B

USD 126.21M

USD 546.59M

USD 19.98M

USD 40.01M

1.78K

EPS每股收益

USD 0.48

股本和储备

USD 2.11B

USD 108.28M

债务利息支出

USD 5.58M

USD 7.31M

USD 546.59M

USD 8.03B

USD 8.33M

USD 174.27M

USD 19.98M

普通股股本

USD 56.4M

109.48

USD 19.11M

USD 194M

销售和管理费用

USD 76.54M

USD 179.26M

贸易债权人

USD 34.66M

应收帐款人

USD 151.55M

	营业费用	更改		日
Agilent	USD 1.44B		9M	2026-03
Align Technology	USD 862.03M		39.18M	2026-03
Bio Techne	USD 235.92M		5.5M	2026-03
BioMarin Pharmaceutical	USD 636.56M		39.61M	2026-03
Bristol-Myers Squibb	USD 20.07B		11.77B	2026-03
Bruker	USD 813.2M		87.7M	2026-03
Charles River Laboratories	USD 875.93M		42.48M	2026-03
Danaher	USD 52.95B		47.61B	2026-03
Dentsply International	USD 1.32B		895M	2026-03
General Electric Aerospace	USD 18.06B		7.11B	2026-03
Henry Schein	USD 3.17B		77M	2026-03
Illumina	USD 852M		51M	2026-03
IQVIA Holdings	USD 6.22B		4.53B	2026-03
Mettler Toledo International	USD 713.2M		64.61M	2026-03
Myriad Genetics	USD 212.8M		16.2M	2025-12
OraSure Technologies	USD 40.35M		2.45M	2025-12
Pacific Biosciences Of California	USD 97.83M		41.29M	2025-12
Pfizer	USD 90.1B		77.19B	2026-03
Repligen	USD 174.27M		3.67M	2026-03
Revvity	USD 628.34M		2.12M	2026-03
Standard Biotools	USD 30.56M		15.16M	2026-03
Thermo Fisher Scientific	USD 9.09B		821M	2026-03
Waters	USD 1.12B		457.15M	2026-03
West Pharmaceutical Services	USD 2.99B		2.35B	2026-03